Notícias21/07/2022 BNT162b2 Vaccine Effectiveness against Omicron in Children 5 to 11 Years of AgeAbstractBACKGROUNDLimited evidence is available on the real-world effectiveness of the BNT162b2 vaccine against coronavirus disease 2019 (Covid-19) and... Repositório Covid-1920/07/2022 Effectiveness of BNT162b2 Vaccine against Omicron in Children 5 to 11 Years of AgeAbstractBACKGROUNDSince it was first identified in early November 2021, the B.1.1.529 (omicron) variant of severe acute respiratory syndrome... Repositório Covid-19 19/07/2022 Ogari Pacheco, ex-presidente da ABIFINA, assume vaga no SenadoOgari Pacheco, ex-presidente da ABIFINA, tomou posse como senador nesta segunda-feira (18/07). Essa é uma importante notícia para o setor... Associado em foco14/07/2022 Brasil assina pacto por desenvolvimento sustentável do AtlânticoDeclaração também foi assinada por União Europeia e mais seis paísesO Brasil, a União Europeia e outros seis países... Outras Notícias14/07/2022 Comunicado de Esclarecimento – Chamadas Públicas nº 12/2022 e 13/2022 do Instituto de Tecnologia em Fármacos“Para que não existam dúvidas, o Instituto de Tecnologia em Fármacos torna público que nas Chamadas Públicas nº 12/2022 e... Associado em foco12/07/2022 Post-recovery COVID-19 and incident heart failure in the National COVID Cohort Collaborative (N3C) studyAbstractCardiac involvement has been noted in COVID-19 infection. However, the relationship between post-recovery COVID-19 and development of de novo... Repositório Covid-1911/07/2022 ABIFINA acompanha discussões de ComexAo longo da última semana, entre os dias 05 e 08 de julho, a ABIFINA participou de diversas discussões relacionadas... Acontece na ABIFINA 11/07/2022 Presidente da ABIFINA participa de encontro com parlamentares e representantes do setor no SenadoA Frente Parlamentar da Química comemorou os dez anos de sua fundação no dia 6 de julho com um encontro... Acontece na ABIFINA11/07/2022 Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodiesSummaryBackgroundIn recent months, Omicron variants of SARS-CoV-2 have become dominant in many regions of the world, and case... Repositório Covid-1911/07/2022 SARS-CoV-2 accelerated clearance using a novel nitric oxide nasal spray (NONS) treatment: A randomized trialSummaryBackgroundAdditional outpatient therapies which are readily accessible will be essential to reduce COVID-19 illness progression in high risk... Repositório Covid-1909/07/2022 Safety and efficacy of mesenchymal stem cells in severe/critical patients with COVID-19: A systematic review and meta-analysisSummaryBackgroundThe present study aims to better understand the efficacy and safety of mesenchymal stromal cells (MSCs) in treating... Repositório Covid-1908/07/2022 Robust long-term immunity to SARS-CoV-2 in patients recovered from severe COVID-19 after interleukin-6 blockadeSummaryBackgroundWhether interleukin-6 (IL-6) blockade in patients with COVID-19 will affect the protective immunity against SARS-CoV-2 has become an... Repositório Covid-19
21/07/2022 BNT162b2 Vaccine Effectiveness against Omicron in Children 5 to 11 Years of AgeAbstractBACKGROUNDLimited evidence is available on the real-world effectiveness of the BNT162b2 vaccine against coronavirus disease 2019 (Covid-19) and... Repositório Covid-19
20/07/2022 Effectiveness of BNT162b2 Vaccine against Omicron in Children 5 to 11 Years of AgeAbstractBACKGROUNDSince it was first identified in early November 2021, the B.1.1.529 (omicron) variant of severe acute respiratory syndrome... Repositório Covid-19
19/07/2022 Ogari Pacheco, ex-presidente da ABIFINA, assume vaga no SenadoOgari Pacheco, ex-presidente da ABIFINA, tomou posse como senador nesta segunda-feira (18/07). Essa é uma importante notícia para o setor... Associado em foco
14/07/2022 Brasil assina pacto por desenvolvimento sustentável do AtlânticoDeclaração também foi assinada por União Europeia e mais seis paísesO Brasil, a União Europeia e outros seis países... Outras Notícias
14/07/2022 Comunicado de Esclarecimento – Chamadas Públicas nº 12/2022 e 13/2022 do Instituto de Tecnologia em Fármacos“Para que não existam dúvidas, o Instituto de Tecnologia em Fármacos torna público que nas Chamadas Públicas nº 12/2022 e... Associado em foco
12/07/2022 Post-recovery COVID-19 and incident heart failure in the National COVID Cohort Collaborative (N3C) studyAbstractCardiac involvement has been noted in COVID-19 infection. However, the relationship between post-recovery COVID-19 and development of de novo... Repositório Covid-19
11/07/2022 ABIFINA acompanha discussões de ComexAo longo da última semana, entre os dias 05 e 08 de julho, a ABIFINA participou de diversas discussões relacionadas... Acontece na ABIFINA
11/07/2022 Presidente da ABIFINA participa de encontro com parlamentares e representantes do setor no SenadoA Frente Parlamentar da Química comemorou os dez anos de sua fundação no dia 6 de julho com um encontro... Acontece na ABIFINA
11/07/2022 Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodiesSummaryBackgroundIn recent months, Omicron variants of SARS-CoV-2 have become dominant in many regions of the world, and case... Repositório Covid-19
11/07/2022 SARS-CoV-2 accelerated clearance using a novel nitric oxide nasal spray (NONS) treatment: A randomized trialSummaryBackgroundAdditional outpatient therapies which are readily accessible will be essential to reduce COVID-19 illness progression in high risk... Repositório Covid-19
09/07/2022 Safety and efficacy of mesenchymal stem cells in severe/critical patients with COVID-19: A systematic review and meta-analysisSummaryBackgroundThe present study aims to better understand the efficacy and safety of mesenchymal stromal cells (MSCs) in treating... Repositório Covid-19
08/07/2022 Robust long-term immunity to SARS-CoV-2 in patients recovered from severe COVID-19 after interleukin-6 blockadeSummaryBackgroundWhether interleukin-6 (IL-6) blockade in patients with COVID-19 will affect the protective immunity against SARS-CoV-2 has become an... Repositório Covid-19
